Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Oppel

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Frontiers in Microbiology|November 12, 2019
The Therapeutic Effect of 1,8-Cineol on Pathogenic Bacteria Species Present in Chronic RhinosinusitisMatthias Schürmann, Felix Oppel, Martin Gottschalk, et al.
Plos Genetics|April 11, 2019
Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignanciesFelix Oppel, Ting Tao, Hui Shi, et al.
Disease Models & Mechanisms|July 12, 2020
<i>suz12</i> inactivation in <i>p53</i>- and <i>nf1</i>-deficient zebrafish accelerates the onset of malignant peripheral nerve sheath tumors and expands the spectrum of tumor typesFelix Oppel, Dong H Ki, Mark W Zimmerman, et al.
Current Oncology Reports|March 29, 2022
Viral and Clinical Oncology of Head and Neck CancersPeter Goon, Matthias Schürmann, Felix Oppel, et al.
Cells|March 6, 2021
Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted XenograftsWenhao Yao, Xu Qian, Sebastian Ochsenreither, et al.
International Journal of Biological Sciences|August 15, 2020
Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neckQiang Xu, Meiyu Fang, Jing Zhu, et al.
Cell Death & Disease|July 19, 2024
Human papillomavirus-associated head and neck squamous cell carcinoma cells lose viability during triggered myocyte lineage differentiationSarah Gendreizig, Laura Martínez-Ruiz, Alba López-Rodríguez, et al.
Molecular Cancer Therapeutics|September 13, 2022
p53 Pathway Inactivation Drives SMARCB1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 InhibitionFelix Oppel, Senyao Shao, Sarah Gendreizig, et al.
BJC Reports|April 15, 2026
Molecular targeting of the meningioma cell signaling circuit reveals drug vulnerabilities including synergy between sulforaphane and focal adhesion kinase inhibitionMichelle C Schwab, Yasmin Kocas, Sarah Gendreizig, et al.
Science Advances|October 20, 2021
Retinoic acid rewires the adrenergic core regulatory circuitry of childhood neuroblastomaMark W Zimmerman, Adam D Durbin, Shuning He, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Frontiers in Microbiology|November 12, 2019
The Therapeutic Effect of 1,8-Cineol on Pathogenic Bacteria Species Present in Chronic RhinosinusitisMatthias Schürmann, Felix Oppel, Martin Gottschalk, et al.
Plos Genetics|April 11, 2019
Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignanciesFelix Oppel, Ting Tao, Hui Shi, et al.
Disease Models & Mechanisms|July 12, 2020
<i>suz12</i> inactivation in <i>p53</i>- and <i>nf1</i>-deficient zebrafish accelerates the onset of malignant peripheral nerve sheath tumors and expands the spectrum of tumor typesFelix Oppel, Dong H Ki, Mark W Zimmerman, et al.
Current Oncology Reports|March 29, 2022
Viral and Clinical Oncology of Head and Neck CancersPeter Goon, Matthias Schürmann, Felix Oppel, et al.
Cells|March 6, 2021
Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted XenograftsWenhao Yao, Xu Qian, Sebastian Ochsenreither, et al.
International Journal of Biological Sciences|August 15, 2020
Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neckQiang Xu, Meiyu Fang, Jing Zhu, et al.
Cell Death & Disease|July 19, 2024
Human papillomavirus-associated head and neck squamous cell carcinoma cells lose viability during triggered myocyte lineage differentiationSarah Gendreizig, Laura Martínez-Ruiz, Alba López-Rodríguez, et al.
Molecular Cancer Therapeutics|September 13, 2022
p53 Pathway Inactivation Drives SMARCB1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 InhibitionFelix Oppel, Senyao Shao, Sarah Gendreizig, et al.
BJC Reports|April 15, 2026
Molecular targeting of the meningioma cell signaling circuit reveals drug vulnerabilities including synergy between sulforaphane and focal adhesion kinase inhibitionMichelle C Schwab, Yasmin Kocas, Sarah Gendreizig, et al.
Science Advances|October 20, 2021
Retinoic acid rewires the adrenergic core regulatory circuitry of childhood neuroblastomaMark W Zimmerman, Adam D Durbin, Shuning He, et al.
Pageof 3